Predicting prostate cancer: analysing the clinical efficacy of prostate cancer risk calculators in a referral population.
about
Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer.European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction of prostate cancer: a multi-institutional study.
P2860
Predicting prostate cancer: analysing the clinical efficacy of prostate cancer risk calculators in a referral population.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Predicting prostate cancer: an ...... tors in a referral population.
@en
type
label
Predicting prostate cancer: an ...... tors in a referral population.
@en
prefLabel
Predicting prostate cancer: an ...... tors in a referral population.
@en
P2093
P2860
P1476
Predicting prostate cancer: an ...... ators in a referral population
@en
P2093
P2860
P2888
P304
P356
10.1007/S11845-015-1291-8
P577
2015-04-07T00:00:00Z